Skip to main content
AstraZeneca Pharma India Limited (NSE:ASTRAZEN)
India flag India · Delayed Price · Currency is INR
8,050.00
-139.50 (-1.70%)
May 14, 2025, 3:29 PM IST

Revenue by Product

Fiscal year is April - March.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19
Tablets
8.71B
Log In
Log In
Log In
Log In
Tablets Growth
15.46%
Log In
Log In
Log In
Log In
Injectables
3.17B
Log In
Log In
Log In
Log In
Injectables Growth
89.19%
Log In
Log In
Log In
Log In
Clinical Trials
898.90M
Log In
Log In
Log In
Log In
Clinical Trials Growth
46.83%
Log In
Log In
Log In
Log In
Inhalation
180.70M
Log In
Log In
Log In
Log In
Inhalation Growth
-10.10%
Log In
Log In
Log In
Log In
Grant of Exclusive Distribution Rights
-
Log In
Log In
Log In
Log In
Other
-
Log In
Log In
Log In
Log In
Other Growth
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is April - March.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19
India
12.02B
Log In
Log In
Log In
Log In
India Growth
28.01%
Log In
Log In
Log In
Log In
International
936.00M
Log In
Log In
Log In
Log In
International Growth
46.14%
Log In
Log In
Log In
Log In